Two distinct, membrane-bound, FAD-containing enzymes catalyze the interconversion of fumarate and succinate: fumarate reductase (used in anaerobic growth) and succinate dehydrogenase (used in aerobic growth). Fumarate reductase subunit C anchors the catalytic components of the fumarate reductase complex to the inner cell membrane and binds quinones.
KEGG: sbo:SBO_4304
Fumarate reductase subunit C (frdC) is a membrane-bound protein component of the fumarate reductase complex in Shigella boydii. This complex plays a critical role in anaerobic respiration by catalyzing the reduction of fumarate to succinate, allowing the bacterium to use fumarate as a terminal electron acceptor under anaerobic conditions.
The frdC subunit specifically functions as an anchor protein that secures the catalytic components of the complex to the membrane. It contains transmembrane domains that form a hydrophobic environment essential for quinol binding and electron transfer processes .
In Shigella species, the fumarate reductase complex is particularly important during infection as it enables bacterial survival in the oxygen-limited environment of the intestinal lumen and within host cells, where access to oxygen is restricted .
The recombinant Shigella boydii frdC protein typically includes specific modifications to facilitate laboratory research applications:
| Feature | Native frdC | Recombinant frdC |
|---|---|---|
| Length | 131 amino acids | 131 amino acids plus tag sequence |
| N-terminal | Native sequence | Often modified with His-tag or other affinity tags |
| Post-translational modifications | Natural bacterial modifications | May lack some modifications depending on expression system |
| Membrane association | Integrated in bacterial membrane | Often solubilized for purification |
| Conformation | Native folding in lipid environment | May have altered folding depending on purification methods |
The recombinant protein generally maintains the primary amino acid sequence (MTTKRKPYVRPMTSTWWKKLPFYRFYMLREGTAVPAVWFSIELIFGLFALKNGPEAWAGFVDFLQNPVIVIINLITLAAALLHTKTWFELAPKAANIIVKDEKMGPEPIIKSLWAVTVVATIVILFVALYW) but includes affinity tags for purification purposes .
While frdC is a structural component of the fumarate reductase complex, FNR (fumarate and nitrate reductase regulator) is a global transcriptional regulator that controls the expression of genes involved in anaerobic respiration, including the frd gene cluster.
Key relationships include:
FNR acts as an oxygen sensor that becomes active under low oxygen conditions
When active, FNR upregulates the expression of the fumarate reductase operon (frdABCD) that includes frdC
In Shigella dysenteriae, the FNR gene is located in proximity to the stx genes encoding Shiga toxin
FNR mediates the blocking of type III secretion system (T3SS) in anaerobic conditions, connecting respiratory adaptation to virulence regulation
This relationship demonstrates how Shigella integrates environmental sensing (oxygen levels) with metabolic adaptation and potentially virulence factor expression .
Successful expression and purification of recombinant Shigella boydii frdC requires specific conditions that accommodate its hydrophobic membrane protein nature:
Expression System and Conditions:
Host organism: E. coli is the preferred expression system due to its genetic similarity to Shigella
Expression vector: Vectors with N-terminal His-tag are commonly used
Induction: IPTG induction at lower temperatures (18-25°C) often yields better results for membrane proteins
Growth conditions: Anaerobic or microaerobic conditions can improve expression by mimicking the natural environment for frdC function
Purification Protocol:
Cell lysis using detergent-based methods (rather than mechanical disruption)
Membrane fraction isolation by ultracentrifugation
Solubilization using mild detergents (e.g., n-dodecyl-β-D-maltoside)
Affinity chromatography using Ni-NTA resin for His-tagged proteins
Size exclusion chromatography for final purification
Storage Recommendations:
Store in Tris/PBS-based buffer with 6% trehalose, pH 8.0
For long-term storage, add 50% glycerol and store at -20°C/-80°C
When designing experiments to study frdC function under anaerobic conditions, consider the following methodological approach:
Experimental Design Framework:
Select appropriate controls:
Positive control: Wild-type Shigella boydii
Negative control: frdC knockout mutant
Complementation control: frdC knockout with plasmid-encoded frdC
Consider implementing a Completely Randomized Design (CRD) for laboratory experiments:
Key parameters to monitor:
Growth rates under anaerobic conditions
Fumarate reduction activity
Membrane potential
ATP production
Expression of related genes
Anaerobic technique options:
Anaerobic chamber with controlled atmosphere
Sealed anaerobic culture vessels with oxygen scavengers
Biological oxygen depletion using reducing agents
The experimental design should incorporate methods to verify anaerobic conditions, such as using resazurin indicators or dissolved oxygen probes to ensure consistent environmental conditions .
To effectively analyze frdC interactions with other components of the respiratory chain, researchers should employ multiple complementary approaches:
Protein-Protein Interaction Methods:
Co-immunoprecipitation (Co-IP): Using antibodies against frdC or its tag to pull down interacting proteins
Bacterial two-hybrid systems: Specifically adapted for membrane protein interactions
Cross-linking mass spectrometry: To capture transient protein-protein interactions within the membrane
Blue native PAGE: For analysis of intact membrane protein complexes
Functional Analysis Methods:
Membrane reconstitution assays: Incorporating purified components into liposomes
Electron transfer measurements: Using artificial electron donors/acceptors
Proton translocation assays: To measure coupling between electron transport and proton movement
Structural Analysis:
Cryo-electron microscopy: For structural analysis of the entire complex
Site-directed mutagenesis: Combined with activity assays to identify critical residues
Hydrogen-deuterium exchange mass spectrometry: To examine protein dynamics and interactions
When designing these experiments, it's essential to maintain anaerobic conditions throughout sample preparation and analysis to preserve the native state of the protein complexes .
Comparative analysis of frdC across Shigella species and related Enterobacteriaceae reveals important evolutionary and functional insights:
| Species | frdC Length | Key Sequence Differences | Functional Implications |
|---|---|---|---|
| S. boydii serotype 4 | 131 aa | Reference sequence | Standard activity profile |
| S. boydii serotype 18 | 131 aa | Conservative substitutions at positions 50 (K→N) and 76 (P→A) | Minor impact on membrane association |
| S. sonnei | 131 aa | 100% identity with S. boydii serotype 4 | Functionally identical |
| S. flexneri | 131 aa | >99% identity | Nearly identical function |
| E. coli | 131 aa | >95% identity | Very similar function, established model system |
Notably, despite the high sequence similarity, there are documented differences in regulation patterns and expression levels that may contribute to pathotype-specific virulence strategies. These differences are likely driven by upstream regulatory elements rather than the protein sequence itself .
The role of frdC in Shigella pathogenesis and intracellular survival is multifaceted and integrated with bacterial metabolism and adaptation to host environments:
Adaptation to anaerobic/microaerobic environments:
The intestinal lumen and intracellular compartments are oxygen-limited
frdC enables anaerobic respiration using fumarate as terminal electron acceptor
This provides metabolic flexibility critical for colonization and persistence
Metabolic reprogramming during infection:
Connection to virulence regulation:
Intracellular survival mechanisms:
Research has demonstrated that mutants impaired in anaerobic respiration show reduced intracellular persistence, highlighting the importance of these metabolic pathways in the infection process .
Recombinant frdC offers several promising avenues for the development of novel antimicrobial strategies against multi-drug resistant Shigella infections:
Structure-based drug design:
Recombinant frdC provides structural templates for designing inhibitors
Targeting the membrane-anchoring function could disrupt respiratory chain assembly
High-resolution structural data combined with in silico screening can identify potential binding pockets
Attenuated vaccine development:
frdC mutants with reduced anaerobic growth capacity could serve as live attenuated vaccine candidates
These would maintain immunogenicity while having reduced virulence
Controlled expression of frdC could create strains with predictable attenuation profiles
Diagnostic applications:
Adjunctive therapy approaches:
Small molecule inhibitors of fumarate reductase activity
Peptides that interfere with frdC membrane integration
Compounds that disrupt interaction between frdC and other complex components
This approach is particularly promising given the increasing prevalence of multidrug-resistant Shigella strains worldwide, including extensively drug-resistant (XDR) strains recently reported in the United States and globally .
Researchers working with recombinant frdC frequently encounter several challenges due to its hydrophobic nature and membrane association:
Additionally, researchers can explore alternative approaches such as:
Fusion strategies with bacterial membrane anchors with C-terminus facing the cytoplasmic site (particularly YcjF variants)
Co-expression with redox partners to improve functional expression
Implementation of glucose dehydrogenase co-expression to provide additional NADP molecules needed for proper folding
These strategies have been shown to increase yield and stability of recombinant membrane proteins from related bacterial systems .
Comprehensive validation of recombinant frdC functional activity requires multiple complementary approaches:
Biochemical Assays:
Reconstitution assays:
Incorporate purified frdC into liposomes or nanodiscs
Add purified frdA and frdB subunits to reconstitute the complex
Measure fumarate reduction using appropriate electron donors (menaquinol)
Spectroscopic methods:
Monitor changes in absorbance at 600 nm during fumarate reduction
Measure quinone reduction/oxidation by absorbance changes
Use fluorescent probes to monitor membrane potential generation
Structural and Biophysical Validation:
Circular dichroism spectroscopy: Verify secondary structure composition
Thermal shift assays: Assess protein stability and ligand binding
Limited proteolysis: Confirm proper folding by resistance to digestion
Functional Complementation:
In vivo complementation: Test if recombinant frdC can restore anaerobic growth in frdC-deficient strains
Membrane integration analysis: Confirm proper insertion into membranes
When analyzing activity data, researchers should compare the kinetic parameters (Km, Vmax) of the recombinant protein to published values for native enzyme complexes. Additionally, consider environmental factors such as pH, ionic strength, and lipid composition that may affect activity measurements .
When faced with data inconsistencies in frdC research across different experimental systems, researchers should implement a systematic approach to identify and address potential sources of variation:
Sources of Experimental Variation:
Expression system differences:
Different E. coli strains may introduce host-specific effects
Variations in expression vectors can affect protein folding and activity
Induction conditions impact protein quality and yield
Purification method effects:
Detergent choice significantly influences membrane protein properties
Presence/absence of lipids during purification affects stability
Different tags may interfere with function to varying degrees
Assay condition variables:
Buffers, pH, and ionic strength affect activity measurements
Temperature variations impact enzyme kinetics
Different electron donors/acceptors yield different activity profiles
Standardization Strategies:
Implement statistical design of experiments (DOE):
Develop reference standards:
Create a well-characterized frdC preparation as internal standard
Include consistent positive and negative controls across experiments
Use orthogonal methods to validate key findings
Metadata documentation:
Record detailed experimental conditions and protocols
Track lot numbers of reagents and materials
Document environmental factors that may influence results